Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Medtronic
MDT
|
+$495M |
| 2 |
ExxonMobil
XOM
|
+$290M |
| 3 |
FedEx
FDX
|
+$273M |
| 4 |
Netflix
NFLX
|
+$262M |
| 5 |
RTX Corp
RTX
|
+$234M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$290M |
| 2 |
EA
Electronic Arts
EA
|
+$280M |
| 3 |
Mastercard
MA
|
+$252M |
| 4 |
RAI
Reynolds American Inc
RAI
|
+$245M |
| 5 |
Johnson & Johnson
JNJ
|
+$242M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.15% |
| 2 | Technology | 16.1% |
| 3 | Financials | 11.82% |
| 4 | Industrials | 9.72% |
| 5 | Consumer Discretionary | 8.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
LGF.B
2276
DELISTED
Lions Gate Entertainment Corp. Class B Non-Voting Shares
LGF.B
| $2.1M | ﹤0.01% |
+66,100
| New | +$1.85M |
|
2277
Sabre
SABR
$892M
| $2.09M | ﹤0.01% |
115,500
-1,152,900
| -91% | -$22.4M |
|
2278
Ascent Industries
ACNT
$136M
| $2.09M | ﹤0.01% |
166,900
+10,581
| +7% | +$119K |
|
2279
Full House Resorts
FLL
$83.5M
| $2.08M | ﹤0.01% |
747,213
+213,300
| +40% | +$550K |
|
2280
Limoneira
LMNR
$251M
| $2.08M | ﹤0.01% |
90,000
+5,400
| +6% | +$120K |
|
2281
Compañía de Cervecerías Unidas
CCU
$2.17B
| $2.08M | ﹤0.01% |
77,300
-22,804
| -23% | -$613K |
|
2282
BlueLinx
BXC
$675M
| $2.08M | ﹤0.01% |
201,060
+34,700
| +21% | +$360K |
|
2283
Kamada
KMDA
$436M
| $2.08M | ﹤0.01% |
432,400
+90,200
| +26% | +$440K |
|
2284
Tyler Technologies
TYL
$13.4B
| $2.07M | ﹤0.01% |
11,900
-11,813
| -50% | -$2.03M |
|
|
ATHX
2285
DELISTED
Athersys, Inc. Common Stock
ATHX
| $2.07M | ﹤0.01% |
+40,224
| New | +$1.81M |
|
|
EVA
2286
DELISTED
Enviva Inc.
EVA
| $2.07M | ﹤0.01% |
69,900
+22,400
| +47% | +$646K |
|
2287
Century Communities
CCS
$2.01B
| $2.06M | ﹤0.01% |
83,454
-47,446
| -36% | -$1.15M |
|
2288
Asure Software
ASUR
$248M
| $2.06M | ﹤0.01% |
165,876
-297,000
| -64% | -$3.68M |
|
|
WG
2289
DELISTED
Willbros Group
WG
| $2.06M | ﹤0.01% |
638,500
+168,600
| +36% | +$405K |
|
2290
ICL Group
ICL
$7.19B
| $2.05M | ﹤0.01% |
461,900
+166,100
| +56% | +$756K |
|
|
JNP
2291
DELISTED
Juniper Pharmaceuticals, Inc. Common Stock
JNP
| $2.05M | ﹤0.01% |
450,650
+49,050
| +12% | +$230K |
|
2292
Peoples Financial Services
PFIS
$714M
| $2.05M | ﹤0.01% |
42,859
+1,059
| +3% | +$45.4K |
|
|
CTO
2293
CTO Realty Growth
CTO
$824M
| $2.05M | ﹤0.01% |
125,624
+18,051
| +17% | +$272K |
|
|
APTI
2294
DELISTED
Apptio, Inc. Class A Common Stock
APTI
| $2.05M | ﹤0.01% |
110,800
-97,800
| -47% | -$1.69M |
|
2295
Moelis & Co
MC
$5.04B
| $2.04M | ﹤0.01% |
47,444
-117,700
| -71% | -$4.71M |
|
|
QUMU
2296
DELISTED
Qumu Corp.
QUMU
| $2.04M | ﹤0.01% |
677,903
+12,491
| +2% | +$34.9K |
|
2297
Stagwell
STGW
$2.25B
| $2.03M | ﹤0.01% |
184,600
-45,100
| -20% | -$454K |
|
|
QTRH
2298
DELISTED
Quarterhill Inc. Common Shares
QTRH
| $2.02M | ﹤0.01% |
1,529,900
+52,897
| +4% | +$72.8K |
|
|
DOC
2299
DELISTED
PHYSICIANS REALTY TRUST
DOC
| $2M | ﹤0.01% |
+112,797
| New | +$2.08M |
|
2300
Heartland Express
HTLD
$991M
| $2M | ﹤0.01% |
79,533
-83,000
| -51% | -$1.81M |
|
Similar funds
Jim Simons's Q3 2017 Portfolio in Review
As of Q3 2017, Jim Simons held 3,587 positions worth $85B, up 8.4% from $78.4B the previous quarter. Its ten largest holdings account for 8.5% of the portfolio.
Jim Simons deployed $2.91B of net new capital in Q3 2017, opening 418 new positions and adding to 1,684 existing holdings. Its largest new stake was ExxonMobil: 3,652,454 shares worth $299M.
By sector, the portfolio is most concentrated in Healthcare at 17% of assets, down from 17% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Electronic Arts, an estimated $280M trimmed.
- Jim Simons's largest Q3 2017 buy was ExxonMobil: 3,652,454 shares worth $299M.
- Jim Simons added most to Medtronic in Q3 2017, an estimated $495M increase.
- Jim Simons's biggest Q3 2017 reduction was Electronic Arts, cutting an estimated $280M.
- Jim Simons fully exited Amazon in Q3 2017, selling an estimated $290M.
- Jim Simons's ten largest holdings make up 8.5% of its $85B portfolio in Q3 2017.
- Jim Simons opened 418 new positions and closed 418 in Q3 2017.
- Jim Simons's portfolio value rose 8.4% quarter-over-quarter to $85B.
Based on Renaissance Technologies's 13F filing for Q3 2017, filed 13 Nov 2017.